UCI finalizes agreement for ViewRay MRI-Guided Radiotherapy System Posted: 2022-05-03 Source: Department of Radiation Oncology News Type: Features & Briefs share UCI's Department of Radiation Oncology has finalized an agreement with ViewRay, Inc., to bring the latest magnetic resonance imaging (MRI)-based linear accelerator to Irvine. The ViewRay device, which first gained FDA approval in 2014, offers the ability to treat hard-to-reach tumors with a high level of precision and accuracy. It is anticipated that clinical trials will be rolled out after this technology is implemented. To learn more, read this press release from ViewRay, Inc. Media Contacts Matt Miller Director, Communications and Public Relations mrmille2@uci.edu Michelle Strombeck Manager, Communications and Public Relations 312-498-8208 mstrombe@hs.uci.edu